HBK Investments’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

HBK Investments’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-626,043	Closed	-$6.18M	–	354
2022 Q3	$6.18M	Hold	626,043	–	–	0.04%	155
2022 Q2	$6.15M	Buy	626,043 +20,200	+3%	+$198K	0.03%	184
2022 Q1	$5.92M	Hold	605,843	–	–	0.02%	220
2021 Q4	$5.94M	Hold	605,843	–	–	0.02%	229
2021 Q3	$5.89M	Buy	605,843 +1,500	+0.2%	+$14.5K	0.02%	224
2021 Q2	$5.85M	Buy	604,343 +4,343	+0.7%	+$42.2K	0.02%	248
2021 Q1	$5.79M	Buy	+600,000	New	+$5.81M	0.03%	219

HBK Investments's SHAC Position: Q4 2022 in Review

HBK Investments sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 626,043 shares — an estimated $6.18M sold.

HBK Investments first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $6.18M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

HBK Investments reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
HBK Investments sold 626,043 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $6.18M.
HBK Investments first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
HBK Investments's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $6.18M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on HBK Investments's 13F filing for Q4 2022, filed 14 Feb 2023.